Company
ORCA Therapeutics
Prostate cancer is the second leading cause of cancer death in men. We are committed to stopping that.
Also known as ORCA Therapeutics B.V.
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Headquarters
- Amsterdam, The Netherlands
- Legal name
- ORCA Therapeutics B.V.
- orca-therapeutics.nl (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are committed to fighting prostate cancer. ORCA aims to significantly improve the lives of prostate cancer patients by developing safe and highly potent oncolytic virus immunotherapies.
Funding snapshot
- Latest round
- Undisclosed2024-09-23
Funding rounds
- Round, 2024
- 2024-09-23
Products
- Other
- ORCA-010
Loading relationship preview